483 Ipsen Bioscience Dec 2017

483 Ipsen Bioscience Dec 2017

Robert Martin FDA, Delaram Moshkelani FDA$119.00 - Available Now

FDA investigators audited the Ipsen Bioscience - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 05 Dec 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Dec 2017
  • Location: Cambridge, United States
  • FEI: 3008532848
Add To Cart